iCo Therapeutics July 1, 2014 Andrew Rae, President - Regeneron - Document - PDFSEARCH.IO

First Page	Meta Content
	iCo Therapeutics July 1, 2014 Andrew Rae, President & CEO[removed]www.icotherapeutics.com / TSX-V: ICO Add to Reading List Document Date: 2014-07-23 09:04:29 Open Document File Size: 2,77 MB Share Result on Facebook Company Isis Pharmaceuticals / AstraZeneca MedImmune & Immune Pharmaceuticals / Diabetic Macular Edema Partners / Alcon Molecular Partners / / Currency EUR / USD / / Facility Device Pipeline / / MedicalCondition JDRF Diabetic Macular Edema / ocular diseases / blindness / Diabetic Macular Edema / / OperatingSystem Isis / / Position candidate for the treatment / / Product Amphotericin B / / Technology Laser / / SocialTag Angiology Vascular endothelial growth factor Diabetic retinopathy Macular edema Ranibizumab Macular degeneration Retina Regeneron Eye disease Ophthalmology

iCo Therapeutics July 1, 2014 Andrew Rae, President & CEO[removed]www.icotherapeutics.com / TSX-V: ICOAdd to Reading List